scispace - formally typeset
J

Jing-Ting Mai

Researcher at Sun Yat-sen University

Publications -  19
Citations -  431

Jing-Ting Mai is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Heart failure & Inflammation. The author has an hindex of 10, co-authored 18 publications receiving 285 citations.

Papers
More filters
Journal ArticleDOI

Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis

TL;DR: Overall, telemedicine was shown to be beneficial, with home-based teletransmission effectively reducing all-cause mortality and HF-related hospital admission, length of stay and mortality in patients with HF.
Journal ArticleDOI

Hydrogen sulfide suppresses endoplasmic reticulum stress-induced endothelial-to-mesenchymal transition through Src pathway

TL;DR: H2S could protect against ER stress-induced EndMT through Src pathway, which may be a novel role for the cardioprotection of H2S.
Journal ArticleDOI

Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress.

TL;DR: In advanced CHF, IL-33 may exert anti-oxidation effects, which may be overwhelmed by concurrently elevated levels of sST2, which is positively correlated with markers of CHF severity.
Journal ArticleDOI

Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4.

TL;DR: The data of the present study suggest that M1-FCs induce EndMT by upregulating CCL-4, and increase endothelial permeability and monocyte adhesion, which may help to elucidate the important role of EndMT in the development of atherosclerosis.
Journal ArticleDOI

LncRNA H19 governs mitophagy and restores mitochondrial respiration in the heart through Pink1/Parkin signaling during obesity.

TL;DR: In this paper, the effects of H19 on metabolic disorders, mitochondrial respiratory function, and mitophagy were investigated, and the regulatory mechanisms of palmitic acid (PA)-treated H9c2 cell and Lep−/− mice were used to investigate cardiac metabolic disorders in vitro and in vivo.